Management of Elevated Ammonia (Hyperammonemia)

Introduction to Hyperammonemia Management

The American Academy of Pediatrics and other medical societies recommend immediately initiating treatment without delay when hyperammonemia is detected, as coma duration and ammonia peak levels directly correlate with irreversible neurological damage and death 1

The American College of Medical Toxicology recommends stopping all protein intake immediately to halt nitrogen load and prevent further ammonia production 1, 2
The Society of Critical Care Medicine suggests securing airway, breathing, and circulation—intubate if neurological status is deteriorating 2, 3
The American Society for Parenteral and Enteral Nutrition recommends beginning aggressive caloric support to prevent catabolism, which worsens hyperammonemia 1, 2

The American Society for Parenteral and Enteral Nutrition suggests providing ≥100 kcal/kg/day through IV dextrose and lipids 1, 3
The European Society for Clinical Nutrition and Metabolism recommends maintaining glucose infusion rate at 8-10 mg/kg/min to prevent protein breakdown 1
The American Society for Parenteral and Enteral Nutrition recommends starting IV lipids at 0.5 g/kg/day, titrating up to 3 g/kg/day for additional calories 1, 3
The European Society for Clinical Nutrition and Metabolism suggests reintroducing protein within 48 hours (starting at 0.25 g/kg/day, increasing to 1.5 g/kg/day) once ammonia decreases to safe levels—prolonged protein restriction causes catabolism 1, 2

The National Institute of Neurological Disorders and Stroke recommends administering L-carnitine: 50 mg/kg loading dose over 90 minutes, then 100-300 mg/kg/day for organic acidemias 1

The American Society of Nephrology recommends initiating hemodialysis or continuous kidney replacement therapy (CKRT) when ammonia levels exceed 300-400 μmol/L despite medical therapy, or with rapidly deteriorating neurological status or coma 1, 2, 3
The European Renal Association suggests that hemodialysis is the most effective method with 95-96% ammonia filtration fraction and provides the fastest ammonia reduction 1
The American Society of Nephrology recommends that CKRT is preferred for hemodynamically unstable patients and can be combined with ECMO support if needed 1
The National Institute of Diabetes and Digestive and Kidney Diseases suggests that peritoneal dialysis is significantly less effective than HD or CKRT 1
The American Society of Nephrology recommends that nitrogen scavengers remain effective during dialysis and should be continued concurrently despite being dialyzed 1

The American Association for Clinical Chemistry recommends checking plasma ammonia levels every 3-4 hours until normalized 1, 2, 3
The National Institute of Diabetes and Digestive and Kidney Diseases suggests monitoring electrolytes closely, especially during CKRT 1, 3

The European Society of Human Genetics recommends investigating the etiology of hyperammonemia, including urea cycle disorders, organic acidemias, severe liver failure, medications, and transient hyperammonemia of the newborn 4

In patients with glufosinate ammonium poisoning, the development of rapidly deteriorating neurological status, coma, or cerebral edema should prompt immediate initiation of hemodialysis or continuous kidney replacement therapy (CKRT). [5][6]
The presence of moderate to severe encephalopathy (e.g., lethargy, hypotonia, absent reflexes, seizures, or coma) constitutes a clear indication for kidney‑replacement therapy. 5
A rapid increase in serum ammonia to > 300 μmol/L within hours despite optimal supportive measures signals the need for dialysis. 5

For hemodynamically unstable patients with glufosinate poisoning, high‑dose continuous venovenous haemodialysis (a form of CKRT) is the preferred modality. 5
When serum ammonia exceeds 1,000 μmol/L, either intermittent hemodialysis or high‑dose CKRT should be started without delay. 6
If ammonia rises above 1,500 μmol/L, a hybrid strategy—initial intermittent hemodialysis followed by CKRT—can achieve rapid ammonia clearance while minimizing rebound hyperammonemia. [7][6]